MVA Members


Contract Research Organisation

Operating worldwide from facilities in France, the Boston area, USA, and Copenhagen, Denmark, CILcare is a unique R&D service company specialized in ear disorders, offering preclinical services and consultancy to accelerate the development (efficacy and safety) of innovative products (drugs, gene & cell therapies, and implantable devices) that target hearing loss, tinnitus, ototoxicity and otic disorders.

Because R&D in hearing is as fascinating as it is complex, preclinical studies require perfectly accurate and reproducible measures using state-of-the-art technology in acoustics and electrophysiology. CILcare’s core values lie in validated and highly robust animal models, allowing to deliver consistent and valid results.

Drawing from an extensive industrial background, CILcare guides partners from target identification to IND, working closely together to advance auditory research and reach a common goal: serving patient populations in need of help.